Seven Mile Advisory’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EP
IA
Seven Mile Advisory's AZN Position: Q2 2026 in Review
Seven Mile Advisory increased its AstraZeneca (AZN) stake by 0.85% in Q2 2026, buying an estimated $3.39K and bringing the position to 2,129 shares worth $404K. The position accounts for 0.27% of the portfolio, ranked #77.
Seven Mile Advisory first reported a position in AZN in Q2 2023 and has held it in 12 quarters since. The position peaked at $416K in Q1 2026. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Seven Mile Advisory held 2,129 shares of AstraZeneca worth $404K as of Q2 2026.
- Seven Mile Advisory bought 18 AstraZeneca shares in Q2 2026, an estimated $3.39K.
- AstraZeneca made up 0.27% of Seven Mile Advisory's portfolio in Q2 2026, its #77 holding.
- Seven Mile Advisory first reported a position in AstraZeneca in Q2 2023 and has held it in 12 quarters since.
- Seven Mile Advisory's AstraZeneca position peaked at $416K in Q1 2026.
- 1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Seven Mile Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.